Roche Holding Ltd. (ROG) Given a CHF 335 Price Target by Goldman Sachs Group, Inc. (The) Analysts
Other research analysts have also issued reports about the stock. Deutsche Bank AG set a CHF 273 price objective on shares of Roche Holding and gave the stock a buy rating in a report on Tuesday, June 6th. Morgan Stanley set a CHF 290 price objective on shares of Roche Holding and gave the stock a buy rating in a report on Monday, May 29th. Jefferies Group LLC set a CHF 305 price objective on shares of Roche Holding and gave the stock a buy rating in a report on Monday, May 29th. J P Morgan Chase & Co reissued a buy rating on shares of Roche Holding in a report on Saturday, May 20th. Finally, Barclays PLC set a CHF 320 price objective on shares of Roche Holding and gave the stock a buy rating in a report on Saturday, May 20th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and seven have assigned a buy rating to the company. The company presently has a consensus rating of Hold and a consensus price target of CHF 271.08.
Roche Holding (VTX:ROG) opened at 245.10 on Tuesday. The firm has a 50-day moving average of CHK 245.91 and a 200 day moving average of CHK 251.86. Roche Holding has a 1-year low of CHK 218.30 and a 1-year high of CHK 273.00. The firm has a market cap of CHK 209.13 billion and a P/E ratio of 21.76.
TRADEMARK VIOLATION NOTICE: This report was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this report on another site, it was stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this report can be accessed at https://www.dailypolitical.com/2017/08/09/roche-holding-ltd-rog-given-a-chf-335-price-target-by-goldman-sachs-group-inc-the-analysts-2.html.
Roche Holding Company Profile
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.